Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Can Fite Biofarma 9M Sales $588.00K Down From $613.00K YoY

Author: Benzinga Newsdesk | November 30, 2023 08:16am
Can Fite Biofarma (AMEX:CANF) reported $588.00 thousand in sales this quarter. This is a 4.08 percent decrease over sales of $613.00 thousand the same period last year.

Posted In: CANF